Exclusive

Publication

Byline

Location

US Patent Issued to The Trustees of the University of Pennsylvania on Oct. 27 for "Anti-Alpha-synuclein monoclonal antibodies, and methods using same" (Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,321, issued on Oct. 27, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Anti-Alpha-synuclein monoclonal ant... Read More


US Patent Issued to TauC3 Biologics on Oct. 27 for "Treatment of tauopathies" (New York Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,322, issued on Oct. 27, was assigned to TauC3 Biologics Ltd. (London). "Treatment of tauopathies" was invented by Daniel G. Chain (New York... Read More


US Patent Issued to The General Hospital, Banner Health, Massachusetts Eye and Ear Infirmary on Oct. 27 for "Anti-apolipoprotein e (APOE) antibodies and polynucleotides thereof" (American, Colombian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,323, issued on Oct. 27, was assigned to The General Hospital Corp. (Boston), Banner Health (Boston) and Massachusetts Eye and Ear Infirmary ... Read More


US Patent Issued to ImmunityBio on Oct. 27 for "Single-chain chimeric polypeptides and uses thereof" (Florida Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,324, issued on Oct. 27, was assigned to ImmunityBio Inc. (San Diego). "Single-chain chimeric polypeptides and uses thereof" was invented by... Read More


US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS on Oct. 27 for "Anti-angiopoietin-like protein 3 (ANGPTL3) antibody and pharmaceutical composition thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,325, issued on Oct. 27, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China). "Anti-angiopoietin-like protein 3 (A... Read More


US Patent Issued to INSTITUTE OF SCIENCE TOKYO on Oct. 27 for "Agent for preventing or treating frontotemporal lobar degeneration" (Japanese Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,326, issued on Oct. 27, was assigned to INSTITUTE OF SCIENCE TOKYO (Tokyo). "Agent for preventing or treating frontotemporal lobar degenera... Read More


US Patent Issued to Chugai Seiyaku on Oct. 27 for "Methods of treatment comprising administering an antibody that promotes disappearance of antigens having plurality of biological activities" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,327, issued on Oct. 27, was assigned to Chugai Seiyaku K.K. (Tokyo). "Methods of treatment comprising administering an antibody that promot... Read More


US Patent Issued to NantBio on Oct. 27 for "Methods of reducing epithelial-mesenchymal transition with an interleukin-8 antibody" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,328, issued on Oct. 27, was assigned to NantBio Inc. (Culver City, Calif.). "Methods of reducing epithelial-mesenchymal transition with an ... Read More


US Patent Issued to Reverb Therapeutics on Oct. 27 for "Cytokine-based therapies and methods" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,329, issued on Oct. 27, was assigned to Reverb Therapeutics Inc. (Vancouver, Canada). "Cytokine-based therapies and methods" was invented b... Read More


US Patent Issued to Amgen on Oct. 27 for "Continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes" (California, Washington, Rhode Island, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,330, issued on Oct. 27, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Continuous manufacturing process for biologics manufacturing b... Read More